Fortrea Holdings (FTRE) Current Assets (2022 - 2026)
Fortrea Holdings (FTRE) reported Current Assets of $881.5 million for Q1 2026, down 9.15% on a YoY basis from $970.3 million in Q1 2025, and down 1.75% quarter-over-quarter from $897.2 million in Q4 2025.
Fortrea Holdings (FTRE) Current Assets (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Current Assets for 5 years, with the latest figure at $881.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 9.15% year-over-year to $881.5 million; the trailing twelve-month figure through Mar 2026 stood at $881.5 million (down 9.15% YoY), and the FY2025 full-year result was $897.2 million, down 5.38% from the prior year.
- Current Assets for Q1 2026 stood at $881.5 million, down from $897.2 million in the prior quarter.
- The five-year high for Current Assets was $1.3 billion in Q3 2023, with the low at $881.5 million in Q1 2026.
- Historically, Current Assets has averaged $1.0 billion across 5 years, with a median of $960.0 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets declined 27.92% — and 2025, when it rose 8.14%.
- Fortrea Holdings' Current Assets stood at $1.2 billion in 2022, then gained by 0.31% to $1.3 billion in 2023, then decreased by 24.19% to $948.2 million in 2024, then fell by 5.38% to $897.2 million in 2025, then declined by 1.75% to $881.5 million in 2026.
- The last three Current Assets figures came in at $881.5 million (Q1 2026), $897.2 million (Q4 2025), and $918.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 881.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 881.50 Mn |
| Dec 31, 2025 | 897.20 Mn |
| Sep 30, 2025 | 918.50 Mn |
| Jun 30, 2025 | 960.00 Mn |
| Mar 31, 2025 | 970.30 Mn |
| Dec 31, 2024 | 948.20 Mn |
| Sep 30, 2024 | 936.90 Mn |
| Jun 30, 2024 | 887.70 Mn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.25 Bn |